A. Valipour (Wien, Austria), D. Cortozi Berton (Porto Alegre (RS), Brazil)
Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
C. Criée (Göttingen, Germany), S. Bahari Javan (Hamburg, Germany), G. Georges (Cary, United States of America), K. Melchior (Hamburg, Germany), R. Hövelmann (Hamburg, Germany), C. Geßner (Leipzig, Germany)
|   |
Effect of Peri-operative Bronchodilator Therapy on Postoperative Pulmonary Function among Lung Cancer Patients with COPD
H. Park (Seoul, Republic of Korea), . Shin (Seoul, Republic of Korea), S. Shin (Seoul, Republic of Korea), D. Kang (Seoul, Republic of Korea), J. Cho (Seoul, Republic of Korea), D. Lee (Seoul, Republic of Korea), S. Lim (Seoul, Republic of Korea)
| |
Influenza and pneumococcal vaccination in patients with COPD
N. Roche (Paris, France), B. Aguilaniu (Grenoble, France), P. Burgel (Paris, France), M. Zysman (Bordeaux, France), D. Hess (Grenoble, France), E. Ouaalaya (Bordeaux, France), T. Tran (Paris, France), C. Raherison (Bordeaux, France)
| |
Alpha-1 antitrypsin deficiency in COPD patients: Time to count it in!
D. Karadogan (Rize, Turkey), S. Özyurt (Rize, Turkey)
| |
Characteristics of new users of single and multiple-inhaler triple therapy for COPD in primary care in England
K. Rothnie (London, United Kingdom), S. Joksaite (London, United Kingdom), A. Ismaila (Collegeville, United States of America), L. Sansbury (Collegeville, United States of America)
| |
Perception and Usage Among Indian Physicians of Long Acting Dual Bronchodilators in COPD: PATTERN Study
L. Pinto (Mumbai, India), A. Khanna (Delhi, India), R. Hegde (Mumbai, India), M. Lopez (Mumbai, India), K. Deshmukh (Mumbai, India), A. Kadakol (Mumbai, India), J. Gogtay (Mumbai, India)
| |
Effect of COPD medications on exacerbation rates in a real-life COPD patient cohort - data from the Czech Multicenter Research Database of COPD.
K. Brat (Brno, Czech Republic), V. Koblizek (Hradec Kralove, Czech Republic), M. Svoboda (Brno, Czech Republic), M. Plutinsky (Brno, Czech Republic), J. Zatloukal (Olomouc, Czech Republic), E. Volakova (Olomouc, Czech Republic), P. Popelkova (Ostrava, Czech Republic), B. Novotna (Prague, Czech Republic), T. Dvorak (Mlada Boleslav, Czech Republic), O. Kudela (Hradec Kralove, Czech Republic), M. Kopecky (Hradec Kralove, Czech Republic), P. Musilova (Jihlava, Czech Republic), E. Kocova (Hradec Kralove, Czech Republic), P. Vanik (Ceske Budejovice, Czech Republic), L. Heribanova (Prague, Czech Republic)
| |
Withdrawal of ICS in patients with COPD
A. Nielsen (Roskilde, Denmark), O. Hilberg (Vejle, Denmark), J. Jensen (Copenhagen, Denmark), A. Løkke (VejleVejle, Denmark)
| |
Patient characteristics that guide medication advice for primary care COPD patients in an electronic service: preliminary results
A. Baron (Groningen, Netherlands), B. Flokstra-De Blok (Groningen, Netherlands), E. Van Heijst (Groningen, Netherlands), J. Meijer (Groningen, Netherlands), E. Metting (Groningen, Netherlands), R. Riemersma (Groningen, Netherlands), H. Kerstjens (Groningen, Netherlands), J. Kocks (Groningen, Netherlands)
| |
Medical quality control intervention for COPD patients in China: a cluster randomized, controlled trial
F. Wang (Guangzhou, China), Z. Liang (Guangzhou, China), Y. Zhou (Guangzhou, China), H. Zhong (Shanghai, China), H. Hu (Macau, China), Y. Yang (Guangzhou, China), W. Shi (Guangzhou, China), Y. Li (Guangzhou, China), N. Zhong (Guangzhou, China), R. Chen (Shenzhen, China)
| |
Dual bronchodilation in real-life COPD management: analysis of patients’ characteristics enrolled in COPD Registry in Russia
A. Belevskiy (Moscow, Russian Federation), N. Kravchenko (Moscow, Russian Federation), L. Samosudova (Moscow, Russian Federation), O. Ostankova (Moscow, Russian Federation)
| |
A specialty wise practice pattern in COPD: A survey of doctors in 3 Asian countries
A. Razak (Kuala Lumpur, Malaysia), R. Chokhani (Kathmandu, Nepal), K. Gunasekera (Colombo, Sri Lanka), A. Mukhopadhyay (Mumbai (Maharashtra), India), V. Gaur (Mumbai (Maharashtra), India), J. Gogtay (Mumbai (Maharashtra), India)
| |
Influence of vaccine prevention of pneumoccocus conjugated vaccine on mortality in patients with COPD
V. Antonov (Chelyabinsk (Chelyabinsk Oblast), Russian Federation), G. Ignatova (Chelyabinsk (Chelyabinsk Oblast), Russian Federation)
| |
Economic impact of delayed multiple-inhaler triple therapy initiation in COPD patients
A. Ismaila (Collegeville, United States of America), R. Wood ( Bollington, United Kingdom), G. Anley (Brentford, United Kingdom), Y. Nam ( Bollington, United Kingdom), D. Bluff ( Bollington, United Kingdom), L. Sansbury (Collegeville, United States of America)
| |
Pharmacological management and risk of mortality after first COPD hospitalization (HERA)
C. Janson (Uppsala, Sweden), B. Nwaru (Gothenburg, Sweden), F. Wiklund (Uppsala, Sweden), G. Telg (Södertälje, Sweden), M. Ekström (Lund, Sweden)
| |
Economic evaluation of the impact of exacerbation frequency in COPD patients treated with single-inhaler triple therapy in Spain: The IMPACT trial
L. Vallejo (Tres Cantos (Madrid), Spain), V. Paly (Philadelphia PA , United States of America), A. Martin (Brentford, United Kingdom), N. Risebrough (Toronto, Canada), C. Abreu (New York, United States of America), J. Izquierdo (Guadalajara, Spain), J. Riesco (Cáceres, Spain), J. Soler-Cataluña (Valencia, Spain), A. Ismaila (Collegeville PA, United States of America)
| |
The effect of methlyxanthines as adjunct to corticosteroids among chronic obstructuve pulmonary disease patients in acute exacerbation: a systematic review and meta-analysis
M. Zamora (Manila, Philippines), D. Guevara (Manila, Philippines), J. Santiaguel (Manila, Philippines), M. Chang (Manila, Philippines)
| |